*Department of Pharmacology, Center for Translational Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA; and †Department of Pharmacology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA.
J Cardiovasc Pharmacol. 2017 Sep;70(3):129-141. doi: 10.1097/FJC.0000000000000483.
G protein-coupled receptor kinases (GRKs) are classically known for their role in regulating the activity of the largest known class of membrane receptors, which influence diverse biological processes in every cell type in the human body. As researchers have tried to uncover how this family of kinases, containing only 7 members, achieves selective and coordinated control of receptors, they have uncovered a growing number of noncanonical activities for these kinases. These activities include phosphorylation of nonreceptor targets and kinase-independent molecular interactions. In particular, GRK2, GRK3, and GRK5 are the predominant members expressed in the heart. Their canonical and noncanonical actions within cardiac and other tissues have significant implications for cardiovascular function in healthy animals and for the development and progression of disease. This review summarizes what is currently known regarding the activity of these kinases, and particularly the role of GRK2 and GRK5 in the molecular alterations that occur during heart failure. This review further highlights areas of GRK regulation that remain poorly understood and how they may represent novel targets for therapeutic development.
G 蛋白偶联受体激酶(GRKs)是一类经典的激酶,其主要功能是调节最大的已知膜受体家族的活性,这些受体影响着人体中每一种细胞类型中的多种生物过程。随着研究人员试图揭示这个仅有 7 个成员的激酶家族如何实现对受体的选择性和协调控制,他们发现了这些激酶越来越多的非典型活性。这些活性包括非受体靶标的磷酸化和激酶非依赖性的分子相互作用。特别是,GRK2、GRK3 和 GRK5 是心脏中表达最丰富的主要成员。它们在心脏和其他组织中的典型和非典型作用,对健康动物的心血管功能以及疾病的发展和进展都有着重要的影响。本综述总结了目前已知的这些激酶的活性,特别是 GRK2 和 GRK5 在心力衰竭时发生的分子改变中的作用。本综述进一步强调了 GRK 调控中仍未被充分了解的领域,以及它们如何可能成为治疗开发的新靶点。